A Double-Blind, Placebo-Controlled, Ascending-Dose, Randomized Study to Evaluate the Safety, Tolerability and Effects on Cognition of AL-108 after 12 Weeks of Intranasal Administration in Subjects with Mild Cognitive Impairment

Publisher: Karger

E-ISSN: 1421-9824|35|5-6|325-339

ISSN: 1420-8008

Source: Dementia and Geriatric Cognitive Disorders, Vol.35, Iss.5-6, 2013-04, pp. : 325-339

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content